Editorials |
From the Department of Physiology, Oita Medical University, Oita, Japan.
Correspondence to Toshiaki Sato, MD, PhD, Department of Physiology, Oita Medical University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan. E-mail tsato@oita-med.ac.jp
Key Words: preconditioning mitochondria protein kinase C protein tyrosine kinase
| Introduction |
|---|
A number of substances and signaling pathways have been proposed to be
involved in mediating the cardioprotective effect of IPC (reviewed in
Downey and Cohen5 ). Nevertheless, considerable evidence
has suggested that ATP-sensitive K+
(KATP) channels may serve as the end effectors in
this process.6 Although the cardioprotective effects were
initially attributed to plasma membrane KATP
channels, the degree of action potential shortening can be divorced
from the extent of protection.7 8 Instead, it now seems
much more likely that KATP channels in
mitochondrial inner membrane (mitoKATP channels)
are the dominant players. The studies of the
mitoKATP channel were facilitated by the
identification of a selective opener and a selective blocker of
mitoKATP channels (selective relative to cardiac
sarcolemmal KATP channels, by at least three
orders of magnitude), namely diazoxide and
5-hydroxydecanoate.9 10 The mitoKATP
channel opener diazoxide mimics the infarct sizelimiting effects of
classic IPC, whereas the mitoKATP channel blocker
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |